mifepristone has been researched along with Animal Mammary Carcinoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guil-Luna, S; Hellmén, E; Martín de las Mulas, J; Millán, Y; Sánchez-Céspedes, R | 1 |
| Bottino, MC; Calvo, JC; Cerliani, JP; Giulianelli, S; Gorostiaga, MA; Gutkind, JS; Lanari, C; Lüthy, IA; Molinolo, AA; Mondillo, C; Pignataro, OP; Rojas, P; Soldati, R | 1 |
| Baldi, A; Cerliani, JP; Giulianelli, S; Gongora, A; Lamb, CE; Lanari, C; Molinolo, A; Sahores, A; Wargon, V | 1 |
| Benakanakere, I; Besch-Williford, C; Carroll, CE; Hyder, SM; Liang, Y | 1 |
| Chua, SS; DeMayo, FJ; Ma, ZQ; Ngan, ES; Tsai, SY | 1 |
| Marx, J | 1 |
| Kim, Y; Lee, EY; Lee, WH; Li, Y; Lin, SC; Poole, AJ | 1 |
| Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T | 1 |
| Budel, V; Cahen, P; Chaboteaux, C; Darro, F; Decaestecker, C; Kiss, R; Leblond, B; Nogaret, JM; Pétein, M; Pourrias, B; Ramos, C; Schoofs, A; Vianna, A | 1 |
| Kokai, Y; Lyttle, CR; Modiano, JF; Nowell, PC; Pykett, MJ; Weiner, DB | 1 |
10 other study(ies) available for mifepristone and Animal Mammary Carcinoma
| Article | Year |
|---|---|
The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dogs; Gonanes; Hormone Antagonists; Mammary Neoplasms, Animal; Mifepristone | 2014 |
Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.
Topics: Animals; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Microscopy, Fluorescence; Mifepristone; Neoplasm Transplantation; Progestins; Receptors, Progesterone; Steroids | 2011 |
Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia.
Topics: Animals; Disease Models, Animal; Female; Fibroblast Growth Factor 2; Hormone Antagonists; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Mifepristone | 2010 |
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Cell Proliferation; Enzyme Activators; Enzyme-Linked Immunosorbent Assay; Female; Guanylate Cyclase; Hormone Antagonists; Humans; Immunoenzyme Techniques; Indazoles; Mammary Neoplasms, Animal; Mice; Mice, Nude; Mifepristone; Piperidines; Progestins; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2013 |
Inducible expression of FGF-3 in mouse mammary gland.
Topics: Animals; Cell Adhesion Molecules; Disease Progression; Epithelial Cells; Female; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Gene Expression Regulation, Developmental; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Mifepristone; Ovariectomy; Proto-Oncogene Proteins; Sexual Maturation | 2002 |
Medicine. Squelching progesterone's signal may prevent breast cancer.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Epithelial Cells; Female; Genes, BRCA1; Genes, p53; Hormone Antagonists; Humans; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mifepristone; Mutation; Progesterone; Receptors, Progesterone | 2006 |
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Epithelial Cells; Estradiol; Estrous Cycle; Female; Genes, BRCA1; Genes, p53; Hormone Antagonists; Humans; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mifepristone; Mutation; Phosphorylation; Progesterone; Proteasome Endopeptidase Complex; Receptors, Estrogen; Receptors, Progesterone; RNA, Small Interfering; Ubiquitin | 2006 |
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic | 2007 |
Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Topics: Alitretinoin; Animals; Anticarcinogenic Agents; Apoptosis; Benzoates; Bexarotene; Breast Neoplasms; Cell Division; Disease Models, Animal; Female; Fenretinide; Hormone Antagonists; Humans; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Mifepristone; Retinoids; Tamoxifen; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured | 1998 |
Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Cat Diseases; Cats; Cell Division; DNA Replication; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Female; Mammary Neoplasms, Animal; Mifepristone; Neoplasms, Hormone-Dependent; Phosphorylation; Progesterone; Progestins; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured | 1991 |